 | • レポートコード：QFJ1-4496 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、転移性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性乳がん治療の市場動向 ・企業の競争状況、市場シェア ・転移性乳がん治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法） ・転移性乳がん治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・転移性乳がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性乳がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性乳がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性乳がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性乳がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Novartis、Merck、Eli Lilly、Johnson & Johnson、Pfizer、AstraZeneca、GlaxoSmithKline、Sun Pharmaceutical、Bayer、Gilead Sciences） ・結論 |
Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.
North America and Europe are the highest revenue generating market for metastatic breast cancer treatment. As incidence rate of diagnosis is high in this region due to advanced healthcare infrastructure and awareness among people. Better reimbursement policies are also the growth factor for metastatic breast cancer treatment market. Asia-Pacific market is expected to be fastest growing market due to the large patient pool, government initiative and government funding for development of new treatments and improving healthcare conditions. Companies in this region mainly focus on generic drugs, but research & development activities are also increasing.
Market Analysis and Insights: Global Metastatic Breast Cancer Treatment Market
The global Metastatic Breast Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Breast Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Breast Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Breast Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Breast Cancer Treatment market.
Global Metastatic Breast Cancer Treatment Scope and Market Size
Metastatic Breast Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Breast Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Breast Surgery
Hormone Therapy
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Novartis
Merck
Eli Lilly
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical
Bayer
Gilead Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Breast Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Biologic Targeted Therapy
1.2.5 Breast Surgery
1.2.6 Hormone Therapy
1.3 Market by Application
1.3.1 Global Metastatic Breast Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Breast Cancer Treatment Market Perspective (2016-2027)
2.2 Metastatic Breast Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Breast Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Breast Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Breast Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Breast Cancer Treatment Industry Dynamic
2.3.1 Metastatic Breast Cancer Treatment Market Trends
2.3.2 Metastatic Breast Cancer Treatment Market Drivers
2.3.3 Metastatic Breast Cancer Treatment Market Challenges
2.3.4 Metastatic Breast Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Breast Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Breast Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Breast Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Breast Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Breast Cancer Treatment Revenue
3.4 Global Metastatic Breast Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Breast Cancer Treatment Revenue in 2020
3.5 Metastatic Breast Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Breast Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Breast Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Breast Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Breast Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Breast Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Metastatic Breast Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Breast Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Breast Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Metastatic Breast Cancer Treatment Market Size (2016-2027)
6.2 North America Metastatic Breast Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Breast Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Breast Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Breast Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Breast Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Breast Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Breast Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Breast Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Breast Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Breast Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Breast Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastatic Breast Cancer Treatment Market Size (2016-2027)
7.2 Europe Metastatic Breast Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Breast Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Breast Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Breast Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Breast Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Breast Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Breast Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Breast Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Breast Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Breast Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Breast Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Breast Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Breast Cancer Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Breast Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Breast Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Breast Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Breast Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Breast Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Breast Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Breast Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Breast Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Breast Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Breast Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Breast Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Breast Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Metastatic Breast Cancer Treatment Introduction
11.1.4 Roche Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Metastatic Breast Cancer Treatment Introduction
11.2.4 Novartis Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Metastatic Breast Cancer Treatment Introduction
11.3.4 Merck Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Metastatic Breast Cancer Treatment Introduction
11.4.4 Eli Lilly Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Metastatic Breast Cancer Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Metastatic Breast Cancer Treatment Introduction
11.6.4 Pfizer Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Metastatic Breast Cancer Treatment Introduction
11.7.4 AstraZeneca Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Metastatic Breast Cancer Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Details
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Metastatic Breast Cancer Treatment Introduction
11.9.4 Sun Pharmaceutical Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.9.5 Sun Pharmaceutical Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Metastatic Breast Cancer Treatment Introduction
11.10.4 Bayer Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Metastatic Breast Cancer Treatment Introduction
11.11.4 Gilead Sciences Revenue in Metastatic Breast Cancer Treatment Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Metastatic Breast Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Biologic Targeted Therapy
Table 5. Key Players of Breast Surgery
Table 6. Key Players of Hormone Therapy
Table 7. Global Metastatic Breast Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metastatic Breast Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Metastatic Breast Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Metastatic Breast Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global Metastatic Breast Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Metastatic Breast Cancer Treatment Market Share by Regions (2022-2027)
Table 13. Metastatic Breast Cancer Treatment Market Trends
Table 14. Metastatic Breast Cancer Treatment Market Drivers
Table 15. Metastatic Breast Cancer Treatment Market Challenges
Table 16. Metastatic Breast Cancer Treatment Market Restraints
Table 17. Global Metastatic Breast Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Metastatic Breast Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top Metastatic Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Breast Cancer Treatment as of 2020)
Table 20. Ranking of Global Top Metastatic Breast Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Metastatic Breast Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Metastatic Breast Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Metastatic Breast Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Metastatic Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Metastatic Breast Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Metastatic Breast Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Metastatic Breast Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Metastatic Breast Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Metastatic Breast Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Metastatic Breast Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Metastatic Breast Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Metastatic Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Metastatic Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Metastatic Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Metastatic Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Metastatic Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Metastatic Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Metastatic Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Metastatic Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Metastatic Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Metastatic Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Metastatic Breast Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Metastatic Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Metastatic Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Metastatic Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Metastatic Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Metastatic Breast Cancer Treatment Product
Table 67. Roche Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Metastatic Breast Cancer Treatment Product
Table 72. Novartis Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Metastatic Breast Cancer Treatment Product
Table 77. Merck Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Metastatic Breast Cancer Treatment Product
Table 82. Eli Lilly Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Metastatic Breast Cancer Treatment Product
Table 87. Johnson & Johnson Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Metastatic Breast Cancer Treatment Product
Table 92. Pfizer Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Metastatic Breast Cancer Treatment Product
Table 97. AstraZeneca Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 102. GlaxoSmithKline Recent Development
Table 103. Sun Pharmaceutical Company Details
Table 104. Sun Pharmaceutical Business Overview
Table 105. Sun Pharmaceutical Metastatic Breast Cancer Treatment Product
Table 106. Sun Pharmaceutical Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 107. Sun Pharmaceutical Recent Development
Table 108. Bayer Company Details
Table 109. Bayer Business Overview
Table 110. Bayer Metastatic Breast Cancer Treatment Product
Table 111. Bayer Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 112. Bayer Recent Development
Table 113. Gilead Sciences Company Details
Table 114. Gilead Sciences Business Overview
Table 115. Gilead Sciences Metastatic Breast Cancer Treatment Product
Table 116. Gilead Sciences Revenue in Metastatic Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 117. Gilead Sciences Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Breast Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Biologic Targeted Therapy Features
Figure 5. Breast Surgery Features
Figure 6. Hormone Therapy Features
Figure 7. Global Metastatic Breast Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Metastatic Breast Cancer Treatment Report Years Considered
Figure 12. Global Metastatic Breast Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Metastatic Breast Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Metastatic Breast Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Metastatic Breast Cancer Treatment Market Share by Regions (2022-2027)
Figure 16. Global Metastatic Breast Cancer Treatment Market Share by Players in 2020
Figure 17. Global Top Metastatic Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Breast Cancer Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Metastatic Breast Cancer Treatment Revenue in 2020
Figure 19. Global Metastatic Breast Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Metastatic Breast Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Metastatic Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 23. North America Metastatic Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 24. North America Metastatic Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 25. United States Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metastatic Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 29. Europe Metastatic Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 30. Europe Metastatic Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 31. Germany Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metastatic Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Metastatic Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Metastatic Breast Cancer Treatment Market Share by Region (2016-2027)
Figure 41. China Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metastatic Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Metastatic Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Metastatic Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metastatic Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Metastatic Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Metastatic Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Metastatic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 68. Sun Pharmaceutical Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 69. Bayer Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Metastatic Breast Cancer Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…- 世界のホルモン不応性乳がん市場規模・現状・予測（2021年-2027年） An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-ca…
- 世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
- 世界の転移性結腸直腸癌治療市場規模・現状・予測（2021年-2027年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の男性乳がん治療市場規模・現状・予測（2021年-2027年） Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation. Market Analysis and Insights…